Hexarelin: Evidence-Based Review: Clinical Data and Practical Applications
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
> # Hexarelin: Evidence-Based Review: Clinical Data and Practical Applications > > Hexarelin is a potent, synthetic, six-amino-acid peptide that belongs to the growth hormone secretagogue (GHS) class of drugs It is known for its robust ability to stimulate the release of growth hormone (GH) from the pituitary gland.
> # Hexarelin: Evidence-Based Review: Clinical Data and Practical Applications
>
> Hexarelin is a potent, synthetic, six-amino-acid peptide that belongs to the growth hormone secretagogue (GHS) class of drugs. It is known for its robust ability to stimulate the release of growth hormone (GH) from the pituitary gland. While it shares similarities with other GH-releasing peptides like GHRP-6 and GHRP-2, Hexarelin is distinguished by its greater potency and a slightly different profile of effects. This article provides a detailed, evidence-based review of Hexarelin, covering its mechanism of action, clinical data, practical applications, and safety considerations.
>
> ## Mechanism of Action: How Hexarelin Works
>
> Hexarelin exerts its primary effect by acting as an agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). This receptor is the natural target for ghrelin, an endogenous peptide hormone that plays a key role in regulating appetite and energy balance, as well as stimulating GH release. By binding to and activating the GHS-R1a, Hexarelin triggers a powerful cascade of intracellular signaling events that result in the pulsatile release of GH from the pituitary gland [1].
>
> Interestingly, research has shown that Hexarelin's mechanism of action is not solely dependent on the GHS-R1a. It also appears to act on a distinct receptor, the CD36 receptor, which is involved in cardiovascular function and lipid metabolism. This dual-receptor activity may explain some of Hexarelin's unique cardioprotective effects, which are not observed with other GHRPs [2]. Furthermore, like other GHRPs, Hexarelin can synergistically enhance the effects of Growth Hormone-Releasing Hormone (GHRH), leading to a more pronounced and sustained release of GH when the two are administered together.
>
> ## Clinical Data and Potential Benefits
>
> Hexarelin has been the subject of numerous clinical studies, which have explored its potential therapeutic applications in a variety of contexts.
>
> Increased Growth Hormone and IGF-1 Levels: The most well-documented effect of Hexarelin is its ability to significantly increase circulating levels of GH and Insulin-like Growth Factor 1 (IGF-1). These hormonal changes can lead to a range of downstream benefits, including increased muscle mass, improved bone density, and enhanced tissue repair [3].
> Cardioprotective Effects: One of the most promising areas of Hexarelin research is its potential to protect the cardiovascular system. Studies have shown that Hexarelin can improve cardiac function, reduce inflammation, and protect against ischemia-reperfusion injury in animal models. These effects appear to be mediated, at least in part, by its interaction with the CD36 receptor [2].
> Neuroprotective and Cognitive Effects: Preclinical studies have suggested that Hexarelin may have neuroprotective and neurotrophic properties. It has been shown to promote the survival of new neurons and improve cognitive function in animal models of neurodegenerative disease [4].
> Improved Body Composition: By stimulating GH and IGF-1, Hexarelin can help to shift the body's metabolic balance towards anabolism, leading to an increase in lean body mass and a reduction in fat mass. This makes it an attractive option for individuals looking to improve their physique and athletic performance.
>
> ## Practical Applications and Dosing Protocols
>
> While Hexarelin is not approved for human use by the FDA, it is used in research settings and by some individuals for performance enhancement and anti-aging purposes. The following information is for educational purposes only and should not be considered medical advice.
>
> A typical dosage of Hexarelin is 1-2 mcg/kg of body weight, administered 1-3 times per day via subcutaneous injection. To maximize its GH-releasing effects, it is often recommended to administer Hexarelin on an empty stomach. For a synergistic effect, it can be stacked with a GHRH analog like Mod GRF 1-29.
>
> | Parameter | Value |
> | :--- | :--- |
> | Typical Dose | 1-2 mcg/kg |
> | Frequency | 1-3 times per day |
> | Administration | Subcutaneous injection |
> | Timing | On an empty stomach |
> | Stacking | Often used with a GHRH analog |
>
> It is important to note that long-term use of Hexarelin can lead to desensitization of the pituitary gland, resulting in a diminished GH response over time. To mitigate this, it is often recommended to cycle Hexarelin, with periods of use followed by periods of discontinuation.
>
> ## Risks and Safety Considerations
>
> Despite its potential benefits, Hexarelin is not without risks and potential side effects.
>
> Increased Cortisol and Prolactin: Like other potent GHRPs, Hexarelin can cause a transient increase in cortisol and prolactin levels. While these elevations are typically mild and short-lived, they can be a concern for some individuals, particularly with high-dose or long-term use.
> Water Retention and Joint Pain: Some users may experience water retention, which can lead to a temporary increase in body weight and joint pain.
> Increased Appetite: While not as pronounced as with GHRP-6, Hexarelin can still cause a noticeable increase in appetite in some individuals.
> Injection Site Reactions: As with any injectable peptide, there is a risk of pain, redness, or irritation at the injection site.
>
> ## Key Takeaways
>
> Hexarelin is a potent, synthetic growth hormone secretagogue that stimulates GH release by acting on the ghrelin receptor and the CD36 receptor.
> Clinical data suggests that Hexarelin can increase GH and IGF-1 levels, exert cardioprotective effects, and improve body composition.
> Practical applications include performance enhancement and anti-aging, with typical doses of 1-2 mcg/kg administered 1-3 times per day.
> Risks and side effects may include increased cortisol and prolactin, water retention, and increased appetite.
>
> > Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
>
> ## References
>
> [1] Imbimbo, B. P., & Walker, R. F. (1997). Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in vitro and in vivo. European Journal of Endocrinology, 136(4), 437-444. https://www.sciencedirect.com/science/article/abs/pii/S0167011597000177
>
> [2] Mosa, R., Huang, L., & LeRoith, D. (2017). Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolism and Reduces Hepatic Steatosis in the MKR Mouse Model. The Journal of Clinical Endocrinology & Metabolism, 102(11), 4065–4075. https://pmc.ncbi.nlm.nih.gov/articles/PMC5659698/
>
> [3] Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B. P., Lenaerts, V., Deghenghi, R., & Camanni, F. (1994). Growth hormone-releasing activity of hexarelin in humans. A dose-response study. European Journal of Endocrinology, 131(3), 329-333. https://pubmed.ncbi.nlm.nih.gov/7957536/
>
> [4] Sirabella, R., Cicalese, A., & Liguori, G. (2013). Hexarelin’s neuroprotective, neurotrophic, and cognitive effects. In Vitamins and Hormones (Vol. 92, pp. 259-286). Academic Press. https://www.sciencedirect.com/topics/neuroscience/hexarelin
>
> [5] Rahilly, S. P., & Shalet, S. M. (1998). Growth Hormone Status during Long-Term Hexarelin Therapy. The Journal of Clinical Endocrinology & Metabolism, 83(5), 1644-1649. https://academic.oup.com/jcem/article-abstract/83/5/1644/2865542
>
---